Press Release: @terumobct takes part in Connecting the Dots: a new film series showcasing the pivotal role of medical technologies to improve healthcare.
To find out more, visit: terumobct.com/Pages/News/Pre…
#apheresis #stemcells
Press Release: @BioSenicSA on its way to find the necessary funds to perform its key clinical trial on chronic Graft-versus-Host Disease.
To read more visit: biosenic.com/sites/default/f…
Press Release: @BioSenicSA provides third quarter 2023 Business Update. To read the full press release, visit: biosenic.com/sites/default/f…
Press Release: @BioSenicSA to draw the final tranches of its present Global Tech Opportunities 15 convertible bonds program and secure runway end of January 2024. To read more, visit: biosenic.com/sites/default/f…
Press Release: @Immutep announces publication of abstracts at ESMO Congress 2023. For more information, and details of their presentations, visit: immutep.com/detail/immutep-a…
#ESMO23 #oncology #LAG3
Press Release: @organabio launches decentralized support division for vaccine and cell and gene therapy clinical trials.
To read more, visit: ibcomms.agency/releases/orga…
#CGT #CDTMO
Press Release: @TrakCel_ appoints Dr. Akshay Peer as Senior Vice President, Product.
To read the full press release, visit: trakcel.com/news/trakcel-app…
#appointment
Press Release: @terumobct launches study with BioCentriq to generate public CAR-T cell data using Terumo BCT’s CGT manufacturing platforms. To read more, visit: terumobct.com/Pages/News/Pre…
Press Release: @BioSenicSA has announced information on the total number of voting rights and shares. To read the full press release, visit: biosenic.com/sites/default/f…
#pressrelease
Press Release: CTMC partners with ScaleReady to automate, close, and scale for greater patient accessibility. To read the full press release, visit: scaleready.com/newsroom/pres…
#partnership #CGTautomation
Press Release: @Immutep announces abstract accepted for presentation at the Society for Immunotherapy of Cancer (SITC) 2023 annual meeting. To read more, visit: immutep.com/detail/immutep-a…
#immunotherapy #LAG3
Press Release: @BioSenicSA performs further analysis of its phase 2 clinical trial data, leading to an optimal administration scheme for its next late-stage trial of arsenic trioxide in #cGvHD. To read the full press release, visit: biosenic.com/sites/default/f…
#clinicaltrial #ATO
Press Release: @CellProthera completes enrollment in Phase I/IIB trial for post-myocardial infarction cell therapy. To read more, visit: cellprothera.com/en/cellprot…
#celltherapy #clinicaltrial #protheracytes #stemcells
Press Release: @terumobct collaborates with MCQ to enable automated gas mixing for expansion of cell and gene therapies. To read the full announcement, visit: terumobct.com/Pages/News/Pre…
#pressrelease #collaboration #cellandgenetherapy
Press Release: @terumobct appoints Jackie Kunzler to Head Research and Development. To read more, visit: terumobct.com/Pages/News/Pre…
#pressrelease #headRandD #appointment
Press Release: @BioSenicSA publishes new evidence of beneficial effects of arsenic trioxide treatment supporting clinical trial for systemic sclerosis. To read more, visit: biosenic.com/sites/default/f…
#arsenictrioxide #systemicsclerosis
Press Release: @BioSenicSA reaches agreement on binding term sheets with main creditors to restructure past financial debts. To read more, visit: biosenic.com/sites/default/f…
#pressrelease #financialupdate #biotech
Press Release: @terumobct's peer-reviewed publication shows hollow fiber-based bioreactors can produce 8x viral vector-producing cells in four days. To read more, visit: terumobct.com/Pages/News/Pre…
#pressrelease #manuscript #publication
Press Release: @BioSenicSA reports half year 2023 results. To read the full press release, visit: biosenic.com/sites/default/f…
#pressrelease #financialresults
Press Release: Cell and gene therapy industry pioneer & GMP expert, Gerhard Bauer, joins Orgenesis Inc. business, Octomera, to drive continued expansion of POCare facilities and service support. For more information, visit: ir.orgenesis.com/press-relea…
#appointment #POCare
